RIG-I immunotherapy overcomes radioresistance in p53-positive malignant melanoma.
Journal of molecular cell biology
View this publicationJournal of molecular cell biology
View this publicationMolecular therapy. Nucleic acids
View this publicationNature communications
View this publicationScientific reports
View this publicationImmunity
View this publicationSignal transduction and targeted therapy
View this publicationPublication categories: Top publication
Immunity
View this publicationFrontiers in immunology
View this publication